Results for tag: "Strontium-89"

Strontium-89 is a radiopharmaceutical used in Nuclear Medicine and Radiopharmacology. It is a radioactive isotope of strontium, and is used to treat bone pain caused by metastatic prostate cancer. It is administered intravenously, and is taken up by the bone, where it emits beta radiation to reduce pain. Strontium-89 is also used to diagnose bone metastases, and to monitor the effectiveness of treatments. The Strontium-89 market is composed of companies that produce and distribute the radiopharmaceutical. These companies include Eckert & Ziegler, Jubilant DraxImage, IBA Molecular, and Nordion. Show Less Read more